Changes in vascular permeability and expression of different angiogenic factors following anti-angiogenic treatment in rat glioma.

Anti-angiogenic treatments of malignant tumors targeting vascular endothelial growth factor receptors (VEGFR) tyrosine kinase are being used in different early stages of clinical trials. Very recently, VEGFR tyrosine kinase inhibitor (Vetanalib, PTK787) was used in glioma patient in conjunction with...

Full description

Bibliographic Details
Main Authors: Meser M Ali, Branislava Janic, Abbas Babajani-Feremi, Nadimpalli R S Varma, A S M Iskander, John Anagli, Ali S Arbab
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2806917?pdf=render